Navigation Links
Regeneron Pharmaceuticals and BioMed Realty Trust Host Ribbon-Cutting Ceremony at the Landmark at Eastview
Date:10/6/2009

r more than two decades Regeneron has discovered, developed, and commercialized medicines for the treatment of serious medical conditions right here in New York," said Empire State Development Chairman and CEO designate, Dennis Mullen. "They have invested millions into the New York economy, and employ more than 1,000, with nearly 750 jobs in Tarrytown and more than 250 in Rensselaer. Today's opening of their new headquarters means we are securing those jobs for New York State. Regeneron is an example of the type of investment which will foster sustainable growth, create jobs, revive our economy and expand opportunities for all New Yorkers."

The new facilities offer environmentally friendly design features, including a white roof to reflect heat, a high efficiency HVAC system, building layouts for laboratories and offices to maximize day lighting, a courtyard located between buildings that maximizes permeable surfaces to reduce water runoff, and extensive use of sustainable materials such as bamboo flooring and low volatility organic compounds. In addition, as part of The Landmark at Eastview campus, employees are provided complimentary shuttle service to the North White Plains and Tarrytown Metro North Stations and convenient access to other public transportation.

The Landmark at Eastview is one of the largest privately-owned, multi-tenant science parks in New York State. The campus consists of eight buildings and over 1.1 million rentable square feet of research and development facilities and high-tech office space. Construction of a third lab-ready building was initiated and completed concurrently with the core and shell construction for Regeneron's two new buildings.

About Regeneron Pharmaceuticals

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection
'/>"/>

SOURCE BioMed Realty Trust, Inc.; Regeneron Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. BioSpace to Host Regeneron Pharmaceuticals Career Fair in Whippany, New Jersey
2. Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology
3. BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Two champions of science, technology, engineering, and ... annual competition for middle and high school students designed ... study. The competition presents students with real-world problems experienced ... Mathematics, and Sciences is a program administered by ...
(Date:1/15/2014)... Freeslate, Inc ., the leading provider of ... one of India’s top five pharmaceutical companies, has received ... for high throughput solid form screening. , Lupin, ... range of quality, affordable generic and branded formulations and ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have ... at 2pm EST (11am PST), “Natural Language Processing: Converting ... how technology can turn raw, heterogeneous data into actionable ... The online webinar will last approximately one hour. , ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 EquitiesIQ, a ... Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical company ... the wound care market. , Free report download: ... with a seasoned management team and Board, which launched ...
Breaking Biology Technology:Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Conn., April 29 Core Informatics announces,that it ... LIMS product,to BioRelix Pharmaceuticals of New Haven, CT. ... the need to establish a,strong data management infrastructure ... the LIMS marketplace, BioRelix choose the Core LIMS., ...
... Aflac and the American,Association for Cancer Research (AACR) ... Development Award for Childhood Cancer Research,endowed by Aflac ... cancer. The award,which includes a two-year grant of ... in San Diego, Calif., to Dr. Charles G. ...
... Points from the First Quarter of 2007 to ... 66.3% - Company Prepares to Launch ... ... leading developer and manufacturer of a broad array of,light-based aesthetic treatment systems, today announced record revenues,and ...
Cached Biology Technology:Core Informatics Delivers Enterprise Core LIMS Installation to BioRelix Pharmaceuticals 2Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 2Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 3Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 2Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 3Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 4Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 5Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 6Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 7Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 8Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 9Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 10Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 11
(Date:4/16/2014)... Sometimes known as Kennedy,s disease, spinal and bulbar muscular atrophy ... progressive muscle weakness and atrophy. Researchers have long considered it ... the cells in the spinal cord and brainstem that control ... the April 16, 2014 online issue of Neuron , ...
(Date:4/16/2014)... store memories improves during childhood, associated with structural changes ... parietal cortices. New research from UC Davis is exploring ... Eventually, that could give insights into disorders that typically ... affect memory, such as schizophrenia and depression. , Located ...
(Date:4/15/2014)... Ohio (April 16, 2014)A new study from the Women,s ... D levels and menopause symptoms. The study was published ... The North American Menopause Society., The authors analyzed the ... a number of menopause symptoms, including hot flashes, night ...
Breaking Biology News(10 mins):Mutant protein in muscle linked to neuromuscular disorder 2How kids' brain structures grow as memory develops 2Low Vitamin D may not be a culprit in menopause symptoms 2
... April 9, 2012 Scientists from Duke University Medical ... switches can define clinically relevant molecular subtypes of ovarian ... prognostic and diagnostic testing. These bimodal genes can define ... to different therapeutic regimens. The researchers, results are ...
... to predictions of which plant species will escape extinction from ... world, posing a great challenge to plants in all ecosystems, ... biology and senior author of the research. Scientists have debated ... are most vulnerable. Sack and two members ...
... (Boston) Researchers at Boston University School of Medicine ... population of pure lung and thyroid progenitor cells in ... and thyroid tissue formation. The research, which will be ... Cell Stem Cell , identifies factors necessary for ...
Cached Biology News:Researchers identify genes that may help in ovarian cancer diagnosis and prognosis 2Which plants will survive droughts, climate change? 2Which plants will survive droughts, climate change? 3Which plants will survive droughts, climate change? 4Which plants will survive droughts, climate change? 5BU researchers derive purified lung and thyroid progenitors from embryonic stem cells 2
Mouse monoclonal antibody raised against a partial recombinant ACTN4. NCBI Entrez Gene ID = ACTN4...
Mouse monoclonal antibody raised against a partial recombinant CAPG. NCBI Entrez Gene ID = CAPG...
Mouse monoclonal antibody raised against a partial recombinant TPR. NCBI Entrez Gene ID = TPR...
... The E. coli protein sample is ... give a consistent pattern when used ... and sample buffer. This sample can ... validate your 2-D system and protocol ...
Biology Products: